NCT00022295View on ClinicalTrials.gov

Phenoxodiol in Treating Patients With Refractory Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 31, 2001

Study Completion Date

October 31, 2007

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

idronoxil

Trial Locations (1)

44195

Cleveland Clinic Taussig Cancer Center, Cleveland

Sponsors
All Listed Sponsors
lead

Kazia Therapeutics Limited

INDUSTRY

NCT00022295 - Phenoxodiol in Treating Patients With Refractory Solid Tumors | Biotech Hunter | Biotech Hunter